Drugs and the renin-angiotensin system in covid-19
- PMID: 32241880
- DOI: 10.1136/bmj.m1313
Drugs and the renin-angiotensin system in covid-19
Conflict of interest statement
Competing interests: JKA is a member of the Centre for Evidence-Based Medicine in Oxford, which jointly runs the EvidenceLive Conference with the BMJ and the Overdiagnosis Conference with some international partners, which are based on a non-profit model. He is an associate editor of BMJ Evidence Based Medicine and was until recently vice-president publications for the British Pharmacological Society. REF was until recently a member of the Birmingham, Sandwell and Solihull Area prescribing committee, is a series editor of The BMJ’s Therapeutic Series, and has an honorary position in University College London. Provenance and peer review: Commissioned; not externally peer reviewed.
Similar articles
-
Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?Pharmacol Res. 2020 Sep;159:104959. doi: 10.1016/j.phrs.2020.104959. Epub 2020 Jun 4. Pharmacol Res. 2020. PMID: 32505834 Free PMC article. No abstract available.
-
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.N Engl J Med. 2020 Apr 23;382(17):1653-1659. doi: 10.1056/NEJMsr2005760. Epub 2020 Mar 30. N Engl J Med. 2020. PMID: 32227760 Free PMC article. No abstract available.
-
Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?J Am Heart Assoc. 2020 Apr 7;9(7):e016509. doi: 10.1161/JAHA.120.016509. Epub 2020 Apr 1. J Am Heart Assoc. 2020. PMID: 32233753 Free PMC article. No abstract available.
-
Outcomes of renin-angiotensin-aldosterone system blockers in patients with COVID-19: a systematic review and meta-analysis.Eur Heart J Cardiovasc Pharmacother. 2020 Sep 1;6(5):335-337. doi: 10.1093/ehjcvp/pvaa074. Eur Heart J Cardiovasc Pharmacother. 2020. PMID: 32671399 Free PMC article. No abstract available.
-
[The RAAS and SARS-CoV-2: A riddle to solve].Hipertens Riesgo Vasc. 2020 Oct-Dec;37(4):169-175. doi: 10.1016/j.hipert.2020.05.005. Epub 2020 May 27. Hipertens Riesgo Vasc. 2020. PMID: 32527699 Free PMC article. Review. Spanish.
Cited by
-
The predictive value of serum amyloid A and C-reactive protein levels for the severity of coronavirus disease 2019.Am J Transl Res. 2020 Aug 15;12(8):4569-4575. eCollection 2020. Am J Transl Res. 2020. PMID: 32913530 Free PMC article.
-
COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease.Eur J Heart Fail. 2020 Jun;22(6):957-966. doi: 10.1002/ejhf.1871. Epub 2020 Jun 24. Eur J Heart Fail. 2020. PMID: 32412156 Free PMC article. Review.
-
Association of calcium channel blocker use with clinical outcome of COVID-19: A meta-analysis.Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102210. doi: 10.1016/j.dsx.2021.102210. Epub 2021 Jul 16. Diabetes Metab Syndr. 2021. PMID: 34298269 Free PMC article.
-
Sodium-glucose co-transporter-2 inhibitors and susceptibility to COVID-19: A population-based retrospective cohort study.Diabetes Obes Metab. 2021 Jan;23(1):263-269. doi: 10.1111/dom.14203. Epub 2020 Oct 19. Diabetes Obes Metab. 2021. PMID: 32991065 Free PMC article.
-
Collider bias undermines our understanding of COVID-19 disease risk and severity.Nat Commun. 2020 Nov 12;11(1):5749. doi: 10.1038/s41467-020-19478-2. Nat Commun. 2020. PMID: 33184277 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous